The Klinique Medical Clinic PCLBKK:KLINIQ 88 Piotroski F-Score is 6 as of Jun. 28, 2026, which is at its 10-year median of 6.00. GuruFocus rates BKK:KLINIQ with a GF Score™ of 88/100 and a GF Value™ of ฿44.60 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 95 Personal Services companies, The Klinique Medical Clinic PCL ranks better than 71.58% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
The Klinique Medical Clinic PCL has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for The Klinique Medical Clinic PCL's Piotroski F-Score or its related term are showing as below:
BKK:KLINIQ'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 6 Max: 7
Current: 6
During the past 7 years, the highest Piotroski F-Score of The Klinique Medical Clinic PCL was 7. The lowest was 4. And the median was 6.
The Klinique Medical Clinic PCL (BKK:KLINIQ) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
The Klinique Medical Clinic PCL Piotroski F-Score Related Terms
The Klinique Medical Clinic PCL Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL Piotroski F-Score Chart
BKK:KLINIQ vs ROL, SCI, HRB: Piotroski F-Score Comparison
For the Personal Services subindustry, The Klinique Medical Clinic PCL's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Klinique Medical Clinic PCL Piotroski F-Score vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where The Klinique Medical Clinic PCL's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
The Klinique Medical Clinic PCL's current Net Income (TTM) was 400.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
The Klinique Medical Clinic PCL's current Cash Flow from Operations (TTM) was 740.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
The Klinique Medical Clinic PCL's return on assets of this year was 0.12112486. The Klinique Medical Clinic PCL's return on assets of last year was 0.1087174.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
The Klinique Medical Clinic PCL's gearing of this year was 0.15069692. The Klinique Medical Clinic PCL's gearing of last year was 0.16570627.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
The Klinique Medical Clinic PCL's current ratio of this year was 1.27249283. The Klinique Medical Clinic PCL's current ratio of last year was 1.41812412.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
The Klinique Medical Clinic PCL's number of shares in issue this year was 220.236. The Klinique Medical Clinic PCL's number of shares in issue last year was 217.425.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
The Klinique Medical Clinic PCL's gross margin of this year was 0.50759915. The Klinique Medical Clinic PCL's gross margin of last year was 0.51757644.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
The Klinique Medical Clinic PCL's asset turnover of this year was 1.1593157. The Klinique Medical Clinic PCL's asset turnover of last year was 1.01901349.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
0
+
0
+
0
+
1
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
The Klinique Medical Clinic PCL has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a Piotroski F-Score of 6 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on The Klinique Medical Clinic PCL and its competitors. This is near median its historical median of 6.00. Over the past decade, The Klinique Medical Clinic PCL's Piotroski F-Score has ranged from 4.00 to 7.00. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #27 out of 95 companies in the Personal Services industry, placing it in the top 28.4%.
Is The Klinique Medical Clinic PCL's Piotroski F-Score too high?
The Klinique Medical Clinic PCL's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 7.00. The Personal Services industry median Piotroski F-Score is 5.00. The Klinique Medical Clinic PCL's value of 6 is 20% above this industry median. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #27 out of 95 companies in the Personal Services industry, which is above the industry midpoint. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's Piotroski F-Score compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #27 out of 95 companies for Piotroski F-Score. This puts The Klinique Medical Clinic PCL in the upper half of its industry. The industry median Piotroski F-Score is 5.00. The Klinique Medical Clinic PCL's value of 6 is 20% above this benchmark. Historically, The Klinique Medical Clinic PCL's own Piotroski F-Score has ranged from 4.00 to 7.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, The Klinique Medical Clinic PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Personal Services company?
The median Piotroski F-Score among Personal Services companies is 5.00, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Klinique Medical Clinic PCL's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.60, compared to a current price of ฿25.75 — trading 42.3% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Personal Services industry median of 5.00. The Klinique Medical Clinic PCL's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current Piotroski F-Score is 6 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿25.75 is trading 42.3% below its estimated GF Value™ of ฿44.60.
GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.
Key valuation signals for BKK:KLINIQ:
Piotroski F-Score: 6 (near median its 10-year median of 6.00)
GF Value™: ฿44.60 vs. price of ฿25.75 (42.3% below fair value)
Industry Position: 20% above the Personal Services median (#27 of 95)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL Business Description
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
88GF Score
Get the complete analysis for BKK:KLINIQ
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
